Kyungbo Pharmaceutical Reports Operating Profit of 6.2 Billion KRW in 2019, Down 64% YoY
[Asia Economy Reporter Minwoo Lee] Chong Kun Dang Holdings announced on the 12th that its subsidiary Kyungbo Pharmaceutical achieved sales of 191.7 billion KRW and an operating profit of 6.2 billion KRW last year. Both sales and operating profit decreased by 4.8% and 64.2%, respectively, compared to the previous year.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- Woman in Her 50s Found Dead 28 Days After Going Missing on Bukhansan Mountain
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
